BR9812443A - 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos - Google Patents

1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos

Info

Publication number
BR9812443A
BR9812443A BR9812443-9A BR9812443A BR9812443A BR 9812443 A BR9812443 A BR 9812443A BR 9812443 A BR9812443 A BR 9812443A BR 9812443 A BR9812443 A BR 9812443A
Authority
BR
Brazil
Prior art keywords
benzazocin
hexahydro
methane
processes
preparation
Prior art date
Application number
BR9812443-9A
Other languages
English (en)
Inventor
Uwe Dr Pschorn
Matthias Dr Grauert
Adrian Dr Carter
Wolf-Dietrich Dr Bechtel
Thomas Dr Weiser
Rainer Dr Palluk
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BR9812443A publication Critical patent/BR9812443A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Patente de Invenção: <B>"1,2,3,4,5,6-HEXAHIDRO-2,6-METANO-3-BENZAZOCIN-10-ó IS SUBSTITUìDOS, PROCESSOS PARA SUA PREPARAçãO E SEU EMPREGO COMO MEDICAMENTOS"<D>. O presente pedido refere-se a novos 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-óis da fórmula geral (I), processos para a sua preparação, bem como seu emprego como medicamento.
BR9812443-9A 1997-09-12 1998-09-09 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos BR9812443A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19740110A DE19740110A1 (de) 1997-09-12 1997-09-12 Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1998/005734 WO1999014199A1 (de) 1997-09-12 1998-09-09 Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
BR9812443A true BR9812443A (pt) 2000-09-26

Family

ID=7842134

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812443-9A BR9812443A (pt) 1997-09-12 1998-09-09 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos

Country Status (38)

Country Link
US (1) US6455538B1 (pt)
EP (1) EP1015433B1 (pt)
JP (1) JP3827528B2 (pt)
KR (1) KR100601008B1 (pt)
CN (1) CN1166640C (pt)
AR (1) AR017095A1 (pt)
AT (1) ATE267811T1 (pt)
AU (1) AU751036B2 (pt)
BG (1) BG64418B1 (pt)
BR (1) BR9812443A (pt)
CA (1) CA2302347C (pt)
CO (1) CO5011117A1 (pt)
CZ (1) CZ296909B6 (pt)
DE (2) DE19740110A1 (pt)
DK (1) DK1015433T3 (pt)
EE (1) EE04398B1 (pt)
ES (1) ES2222612T3 (pt)
HR (1) HRP980502B1 (pt)
HU (1) HUP0004588A3 (pt)
ID (1) ID24173A (pt)
IL (1) IL134572A (pt)
MY (1) MY120550A (pt)
NO (1) NO315650B1 (pt)
NZ (1) NZ503710A (pt)
PE (1) PE122899A1 (pt)
PL (1) PL198486B1 (pt)
PT (1) PT1015433E (pt)
RS (1) RS49888B (pt)
RU (1) RU2218334C2 (pt)
SA (1) SA98190765B1 (pt)
SK (1) SK284670B6 (pt)
TR (1) TR200000697T2 (pt)
TW (1) TW505645B (pt)
UA (1) UA61973C2 (pt)
UY (2) UY25175A1 (pt)
WO (1) WO1999014199A1 (pt)
YU (1) YU12000A (pt)
ZA (1) ZA988285B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6683089B2 (en) 2002-02-02 2004-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers
US6828311B2 (en) 2002-05-29 2004-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Formulation for the parenteral application of a sodium channel blocker
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
US20030235576A1 (en) * 2002-06-15 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of ischaemic conditions
DE10226814A1 (de) * 2002-06-15 2004-01-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung ischämischer Zustände
NZ567540A (en) 2005-12-22 2010-07-30 Newron Pharm Spa 2-Phenylethylamino derivatives as calcium and/or sodium channel modulators
DK2155663T3 (en) 2007-06-15 2018-01-22 Newron Pharm Spa SUBSTITUTED 2- [2- (PHENYL) ETHYLAMINO] ALKANAMIDE DERIVATIVES AND THEIR USE AS SODIUM AND / OR CALCIUM CHANNEL MODULATORS
HUE030031T2 (en) 2011-06-27 2017-04-28 Newron Pharm Spa Fluorinated arylalkylaminocarboxamide derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
US4208523A (en) 1978-11-30 1980-06-17 Sterling Drug Inc. 11-Lower-alkyl-, 11-phenyl-lower-alkyl- and 11-cyclo-lower-alkyl-lower-alkyl-hexahydro-2,6-methano-3-benzazocines
US5607941A (en) * 1992-06-26 1997-03-04 Boehringer Ingelheim Kg Useful for treating neurodegenerative diseases
DE4121821A1 (de) 1991-07-02 1993-01-14 Boehringer Ingelheim Kg Neue benzomorphane und ihre verwendung als arzneimittel
DE19528472A1 (de) 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
ID24173A (id) 2000-07-13
EE200000129A (et) 2001-02-15
CN1166640C (zh) 2004-09-15
NO315650B1 (no) 2003-10-06
JP3827528B2 (ja) 2006-09-27
HUP0004588A3 (en) 2002-10-28
UA61973C2 (en) 2003-12-15
HRP980502A2 (en) 1999-06-30
ES2222612T3 (es) 2005-02-01
DK1015433T3 (da) 2004-09-27
CO5011117A1 (es) 2001-02-28
PL198486B1 (pl) 2008-06-30
NO20001288D0 (no) 2000-03-10
CZ296909B6 (cs) 2006-07-12
UY25175A1 (es) 2000-12-29
CA2302347A1 (en) 1999-03-25
BG64418B1 (bg) 2005-01-31
SK3342000A3 (en) 2000-09-12
RS49888B (sr) 2008-08-07
CA2302347C (en) 2008-06-17
RU2218334C2 (ru) 2003-12-10
SK284670B6 (sk) 2005-08-04
AU9624298A (en) 1999-04-05
IL134572A0 (en) 2001-04-30
MY120550A (en) 2005-11-30
CN1269790A (zh) 2000-10-11
ATE267811T1 (de) 2004-06-15
KR100601008B1 (ko) 2006-07-19
AR017095A1 (es) 2001-08-22
TR200000697T2 (tr) 2001-01-22
JP2001516747A (ja) 2001-10-02
WO1999014199A1 (de) 1999-03-25
DE59811477D1 (de) 2004-07-01
HRP980502B1 (en) 2005-02-28
PE122899A1 (es) 1999-12-06
PT1015433E (pt) 2004-08-31
IL134572A (en) 2005-05-17
NO20001288L (no) 2000-03-13
SA98190765B1 (ar) 2006-06-10
PL339061A1 (en) 2000-12-04
TW505645B (en) 2002-10-11
EE04398B1 (et) 2004-12-15
DE19740110A1 (de) 1999-03-18
YU12000A (sh) 2002-11-15
BG104232A (en) 2000-10-31
CZ2000894A3 (cs) 2000-09-13
HUP0004588A2 (hu) 2001-07-30
KR20010023879A (ko) 2001-03-26
EP1015433A1 (de) 2000-07-05
UY25439A1 (es) 1999-11-17
US6455538B1 (en) 2002-09-24
NZ503710A (en) 2002-04-26
EP1015433B1 (de) 2004-05-26
AU751036B2 (en) 2002-08-08
ZA988285B (en) 1999-03-12

Similar Documents

Publication Publication Date Title
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
AR015349A1 (es) Nuevas modificaciones cristalinas del 2-amino-4-(4-fluorbencilamino)-1-etoxicarbonil-aminobenceno y procedimiento para prepararlos, utilizacion de losmismas y medicamento que las contienen
SE0001899D0 (sv) New compounds
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
IT1276071B1 (it) Compositi ad attivita&#39; anti-infiammatoria
BR9814592A (pt) &#34;compostos azopolicìclicos condensados com arila&#34;
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
FR2713635B1 (fr) Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
BR9808255A (pt) Amidas de ácido aminossalicìlico substituìdas com efeito fungicida e produtos intermediários para sua preparação.
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
BR9811093A (pt) Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo)
EA199700380A1 (ru) Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции
BR0007514A (pt) Macrolìdeos com atividade anti-inflamatória
BR9909548A (pt) Fenilpiridazinonas substituìdas
BR9911978A (pt) Feniluracilas substituìdas
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
BR9907112A (pt) Composto, medicamento, e, uso de um composto
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
BR9705143A (pt) Derivados de 10,13,15-trioxatriciclo [9.2.1.1(9.6)] -pentadecanona, processo para a sua preparação e medicamentos que contém estes compostos
BR0013313A (pt) Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO DISPOSTO NOS ARTIGOS 8O, 11, 13, 24 E 25 DA LPI